Zevra

Celebration, United States Founded: 2006 • Age: 20 yrs Listed
Marketing services are provided to biopharma companies.

About Zevra

Zevra is a publicly listed company based in Celebration (United States) founded in 2006 by Christal MM Mickle. Marketing services are provided to biopharma companies. The company has 59 employees. Zevra has completed 1 acquisition, including Acer Therapeutics. Its chief executive, as recorded, is Neil F McFarlane. Zevra offers products and services including MIPLYFFA, OLPRUVA, and AZSTARYS. Its focus areas include Biopharma Outsourcing and Marketing Services. Its legal entity is Zevra Therapeutics, Inc. Its competitors include Supreme Optimization, Woodward Pharma Services and CMI Media Group.

Company details

Zevra was established in 2006 in Celebration, United States, as a provider of marketing services focused on the biopharma sector. Operations center on supporting pharmaceutical and biotechnology firms through targeted marketing strategies. Services include promotional campaigns, market analysis, and communication tools tailored to industry needs. The company is led by co-founder Christal MM Mickle and CEO Neil F McFarlane, with activities conducted primarily in the U.S. market.

  • Headquarters Celebration, United States
  • Employees 59
  • Founders Christal MM Mickle
  • Stage Public
  • Sectors
    Healthcare
  • Website zevra.com
  • Social LinkedIn X Facebook
  • Legal Name Zevra Therapeutics, Inc.
Key Metrics
  • Annual Revenue
    $106.47 M (USD)
    350.91
    as on Dec 31, 2025
  • Net Profit
    $77.58 M (USD)
    as on Dec 31, 2025
  • EBITDA
    -$179 K (USD)
    99.78
    as on Dec 31, 2025
  • Employee Count
    59
  • Investments & Acquisitions

Products & Services of Zevra

Zevra offers a comprehensive portfolio of products and services, including MIPLYFFA, OLPRUVA, and AZSTARYS.

MIPLYFFA
Therapeutic Drug

Treats specific rare diseases through targeted therapy approaches.

OLPRUVA
Therapeutic Drug

Addresses unmet needs in rare metabolic disorders effectively.

AZSTARYS
Therapeutic Drug

Focuses on neurological conditions with innovative treatment methods.

People of Zevra

29 people are tracked at Zevra (24 in leadership, 5 in team); the tracked headcount is 59.

NameRoleGroup
Christal MM Mickle
Co-FounderLeadership
Neil F McFarlane
CEOLeadership
Lauren Hitchins
Director, Strategic Operations And Medical ExcellenceLeadership
David Rowe Wood
Head Of Field Medical AffairsLeadership
Adrian Quartel
Chief Medical OfficerLeadership
Timothy Sangiovanni
Senior Vice President, Corporate ControllerLeadership
Rene A. Braeckman
Senior Vice President, Clinical DevelopmentLeadership
Laduane Clifton
Chief Financial Officer, Secretary And TreasurerLeadership
R. Laduane Clifton
Chief Financial Officer, Secretary, & TreasurerLeadership
Christopher M. Lauderback
Senior Vice President, ManufacturingLeadership
Adam Smith
Vice President, Business Development And Commercial OperationsLeadership
Louise Himmelstrup
Vice President EU Regulatory AffairsLeadership
Sven Guenther
Chief Scientific OfficerLeadership
Sanjib Bera
VP Drug DiscoveryLeadership
Abbi M.
Vp, Legal AffairsLeadership
Douglas Commerce
Sr. Director, CMC Quality AssuranceLeadership
Tanya Hayden
Senior Vice President, Chief Of StaffLeadership
Mark Meier
Sr. Director, MarketingLeadership
Nichol Ochsner
Vice President, Investor Relations And Corporate CommunicationsLeadership
Corinna Wetzel
Senior Director Product DevelopmentLeadership

9 more people are available in the full profile.

Premium access

Complete people profiles for Zevra

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Zevra

Zevra is a publicly listed company on the NASDAQ with ticker symbol ZVRA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date16 Apr 2015
  • Listed onNASDAQ: ZVRA
  • Listed entityZevra Therapeutics, Inc.
  • Exchange sectorHealth technology
  • ISINUS4884452065
  • Share price$10.39 (-8.22% on the day) · 2026-10-13
  • Market capitalisation$617.0M
  • Price to earnings11.2
  • EPS (diluted, trailing year)$0.93
  • Volume (last session)1,090,678

Financials of Zevra

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$106.5M$77.6M-$179,000
2024$23.6M-$105.5M-$80.6M
2023$27.5M-$46.0M-$48.6M
2022$10.2M-$26.8M-$24.0M
2021$28.6M-$8.6M$8.0M
Premium access

Detailed financial statements for Zevra

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Zevra

Zevra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Acer Therapeutics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Treatments for ultra-rare diseases like vEDS and MSUD are developed.
acertx.comCambridge, United States1991Nov 2023••••
Premium access

Complete acquisition details for Zevra

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Zevra

3 dated milestones of Zevra across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Zevra is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Acer Therapeutics.

Competitors of Zevra

Zevra has 3 listed competitors in our database. They include Supreme Optimization, Woodward Pharma Services and CMI Media Group.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
supremeopti.com2012San Juan, Puerto Rico
Digital marketing services are offered to the life sciences sector.
woodwardpharma.com2015Wixom, United States
Pharmaceutical company that provides outsourced marketing, sales, and commercial services for pharmaceutical companies
cmimediagroup.com1989Cherry Hill, United States
Full-service media agency is operated for healthcare and pharmaceutical marketing.
Premium access

Detailed competitors of Zevra

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Zevra

The website of Zevra (zevra.com) receives about 8K visits a month.

  • Monthly visits
    8K

    ▲ 9.4% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Zevra (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zevra

Premium access

Complete news archive for Zevra

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zevra

Zevra was founded in 2006.

Zevra is headquartered in Celebration, United States. It is registered at Celebration, Florida, United States.

Neil F McFarlane is the CEO of Zevra, as recorded in our data.

Zevra has 59 employees.

Annual revenue of Zevra is $106.47M as on Dec 31, 2025.

Zevra was established in 2006 in Celebration, United States, as a provider of marketing services focused on the biopharma sector. Operations center on supporting pharmaceutical and biotechnology firms through targeted marketing strategies. Services include promotional campaigns, market analysis, and communication tools tailored to industry needs. The company is led by co-founder Christal MM Mickle and CEO Neil F McFarlane, with activities conducted primarily in the U.S. market.

Zevra's top competitors include CMI Media Group, Supreme Optimization and Woodward Pharma Services.

Zevra offers MIPLYFFA, OLPRUVA, and AZSTARYS.

Yes, Zevra is publicly traded on NASDAQ under the ticker symbol ZVRA.

Zevra has made 1 acquisition, including Acer Therapeutics.

Zevra operates through Zevra Therapeutics, Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available